Filtros de búsqueda

Lista de obras de Daniel S Chen

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

artículo científico publicado en 2012

Abscopal effect in a patient with melanoma

artículo científico publicado en 2012

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

artículo científico publicado en 2013

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.

artículo científico publicado en 2016

BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.

artículo científico publicado en 2011

Cellular immunotherapy: antigen recognition is just the beginning.

artículo científico publicado en 2005

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

artículo científico publicado en 2018

Combinations of Bevacizumab With Cancer Immunotherapy

scientific article published on 01 July 2018

De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute.

artículo científico publicado en 2016

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

scientific article published on 01 March 2020

Detection and characterization of cellular immune responses using peptide-MHC microarrays

artículo científico publicado en 2003

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

artículo científico publicado en 2013

Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).

artículo científico publicado en 2016

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

artículo científico publicado en 2020

Introduction by the Guest Editors: Bevacizumab

scientific article published on 01 July 2018

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

artículo científico publicado en 2014

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray

artículo científico publicado en 2005

Molecular biomarker analyses using circulating tumor cells

artículo científico publicado en 2010

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

artículo científico publicado en 2012

New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016

artículo científico publicado en 2017

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

artículo científico publicado en 2014

Retroviral Vector-Mediated Transfer of an Antisense Cyclin G1 Construct Inhibits Osteosarcoma Tumor Growth in Nude Mice ⬇️

artículo científico publicado el 20 de septiembre de 1997

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab

artículo científico publicado en 2019

T cells use two directionally distinct pathways for cytokine secretion.

artículo científico publicado en 2006

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

artículo científico publicado en 2018

Top 10 Challenges in Cancer Immunotherapy

scientific article published on 01 January 2020

VEGF in Signaling and Disease: Beyond Discovery and Development

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda